Dr. Martin Makary testifies during his confirmation hearing before the Senate Committee on Health, Education, Labor, and Pensions Committee on March 06, 2025, in Washington, DC. This story was ...
WASHINGTON (AP) — U.S. regulators will begin offering faster reviews to new medicines that administration officials deem as promoting “the health interests of Americans,” under a new initiative ...
CHMP is reviewing avacopan, a drug authorized in the EU for treating adults with severe, active granulomatosis with polyangiitis or microscopic polyangiitis.
A study found that clinical pharmacist-led reviews of hospital medications for older adults with hip fractures were linked to significantly lower rates of adverse drug reactions (ADRs). The research, ...
People with type 2 diabetes who receive comprehensive medication reviews (CMRs) had better adherence with oral antidiabetic drugs and statin utilization compared to those who did not receive CMRs, a ...
U.S. regulators will begin offering faster reviews to new medicines that administration officials deem as promoting “the health interests of Americans,” under a new initiative announced Tuesday. Food ...